Concepedia

Publication | Open Access

Antigenic response to <scp>CT</scp>‐P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition

23

Citations

23

References

2018

Year

Abstract

These results strongly support a similar antigenic profile for infliximab originator and CT-P13, and point toward a safe switching between the two drugs in anti-drug antibody negative patients.

References

YearCitations

Page 1